ACTRN12617000579392已完成1 期
Drug Interaction Study to Evaluate the Effect of DUR-928 on the Pharmacokinetics of a Single Oral Dose of Midazolam in healthy participants.
INC Research0 个研究点目标入组 18 人开始时间: 2017年4月24日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Years 至 55 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A drug-drug interaction study of DNL343 on midazolam in healthy participantsISRCTN26840121Denali Therapeutics Inc.16
撤回
4 期
Study on the pharmacokinetic interaction between diclofenac and tamoxifen in patients with breast cancer. the DICLOTAM studyNL-OMON48096Erasmus MC, Universitair Medisch Centrum Rotterdam14
已完成
1 期
Pharmacokinetic drug-drug interaction study between oral 300 mg netupitant/0.50 mg palonosetron fixed dose combination (Akynzeo®) and oral dexamethasone to evaluate the duration of the CYP3A4 inhibition in healthy subjectsInhibitory effect on CYP3A4ISRCTN93845260Helsinn Healthcare SA24
尚未招募
Unknown
PotentialDrug-Drug Interactions in Patients AttendingMedicine OPD in a Tertiary Care HospitalCTRI/2024/07/071259R G Kar Medical College and Hospital
已完成
不适用
A drug-drug interaction study between the novel anti-HCV agent DAclatasvir and The antidiabetic agent mEtformine in healthy volunteers.HCV1001842410047438diabetes mellitusHepatitis CNL-OMON42748Apotheek20